title: Dimebon as a potential therapy for Alzheimer's disease.
abstract: Excellent treatment for Alzheimer's disease remains an unmet medical need. Although current therapies improve patients' abilities compared to placebo and temporarily maintain performance above baseline on a number of outcome measures, additional therapies are needed to augment the benefits over baseline and to prolong these improvements.
authors.affiliation: Alzheimer's Disease Research, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: Rachelle S
authors.initials: RS
authors.lastname: Doody
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D006633:Histamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D006633:Histamine Antagonists; D007211:Indoles; C010119:latrepirdine